View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
Baxter BioPharma Solutions|31 January 2020

Baxter BioPharma Solutions – Halle facility

Cancer incidence is on the rise and cytotoxic therapies continue to be at the centre of oncology treatment programs. Through this latest expansion in Halle, Germany, Baxter BioPharma Solutions will continue to support pharmaceutical companies' effort

Cancer incidence is on the rise and cytotoxic therapies continue to be at the centre of oncology treatment programs. Through this latest expansion in Halle, Germany, Baxter BioPharma Solutions will continue to support pharmaceutical companies’ efforts to address patient needs worldwide.

Contact your Baxter BioPharma Solutions representative to schedule a tour of our state-of-the-art addition.

About the Expansion:

Pharma Production Building E (PPE) is Baxter’s latest major expansion in Halle. The expanded facility is dedicated to contract manufacturing of oncology products. Our long-time experience in sterile manufacturing has been utilized by our engineers to design a building with a strong focus on our customers and their need for flexibility, product quality and high yield.

Transparency is one of the key features of the new building. Glass was used to enhance the visibility of the manufacturing lines and processes. This “facility made out of glass” concept allows you to view the actual critical manufacturing processes in a cleanroom class A while conveniently standing in a cleanroom class D.

A prefilled syringe is a convenient primary packaging option for delivery of parenteral medication.
Manufacturing in multi-product facilities affords numerous advantages but also presents significant challenges.
The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting from annual strain...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU